Phase 2 Open-label, Single-arm, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Camostat Mesylate in Patients with Protein-losing Enteropathy after Fontan Operation-Preliminary Outcome

被引：0
|
作者：
Park, Woo Young
Kim, Gi Beom
Lee, Sang
Baek, Jae Suk
Kim, Soo Jin
Jung, Jowon
Hyun, Myung Chul
Lim, Young Tae
Lee, Hyoung-Doo
Ko, Hoon
Lee, Joowon
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
Camostat mesylate; protein-losing enteropathy; Fontan operation;
D O I：
10.1161/circ.150.suppl_1.4144560
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4144560
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Efficacy and safety of trimethoprim-sulfamethoxazole in HIV-infected patients with cerebral toxoplasmosis in Brazil: a single-arm open-label clinical trial
    Pellegrino, Daniela
    Gryschek, Ronaldo
    Penalva de Oliveira, Augusto Cesar
    Marcusso, Rosa
    Correia, Ademir
    Vidal, Jose E.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2019, 30 (12) : 1156 - 1162
  • [42] Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
    Cuchel, Marina
    Meagher, Emma A.
    Theron, Hendrik du Toit
    Blom, Dirk J.
    Marais, A. David
    Hegele, Robert A.
    Averna, Maurizio R.
    Sirtori, Cesare R.
    Shah, Prediman K.
    Gaudet, Daniel
    Stefanutti, Claudia
    Vigna, Giovanni B.
    Du Plessis, Anna M. E.
    Propert, Kathleen J.
    Sasiela, William J.
    Bloedon, LeAnne T.
    Rader, Daniel J.
    LANCET, 2013, 381 (9860): : 40 - 46
  • [43] Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial
    Kumeso, Victor Kande Betu
    Kalonji, Wilfried Mutombo
    Rembry, Sandra
    Mordt, Olaf Valverde
    Tete, Digas Ngolo
    Pretre, Adeline
    Delhomme, Sophie
    Kyhi, Medard Ilunga Wa
    Camara, Mamadou
    Catusse, Julie
    Schneitter, Stefan
    Nusbaumer, Morgane
    Miaka, Erick Mwamba
    Mbembo, Helene Mahenzi
    Mayawula, Joseph Makaya
    Camara, Mariame Layba
    Massa, Felix Akwaso
    Badibabi, Lewis Kaninda
    Bonama, Augustin Kasongo
    Lukula, Papy Kavunga
    Kalonji, Sylvain Mutanda
    Philemon, Phyll Mariero
    Nganyonyi, Ricardo Mokilifi
    Mankiara, Hugues Embana
    Nguba, Andre Asuka Akongo
    Muanza, Vincent Kobo
    Nasandhel, Ernest Mulenge
    Bambuwu, Aimee Fifi Nzeza
    Scherrer, Bruno
    Strub-Wourgaft, Nathalie
    Tarral, Antoine
    LANCET INFECTIOUS DISEASES, 2023, 23 (04): : 463 - 470
  • [44] Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study
    Yoko Edahiro
    Kohshi Ohishi
    Akihiko Gotoh
    Katsuto Takenaka
    Hirohiko Shibayama
    Takayuki Shimizu
    Kensuke Usuki
    Kazuya Shimoda
    Masafumi Ito
    Scott A. VanWart
    Oleh Zagrijtschuk
    Albert Qin
    Hiroaki Kawase
    Narihisa Miyachi
    Toshiaki Sato
    Norio Komatsu
    Keita Kirito
    International Journal of Hematology, 2022, 116 : 215 - 227
  • [45] Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study
    Edahiro, Yoko
    Ohishi, Kohshi
    Gotoh, Akihiko
    Takenaka, Katsuto
    Shibayama, Hirohiko
    Shimizu, Takayuki
    Usuki, Kensuke
    Shimoda, Kazuya
    Ito, Masafumi
    VanWart, Scott A.
    Zagrijtschuk, Oleh
    Qin, Albert
    Kawase, Hiroaki
    Miyachi, Narihisa
    Sato, Toshiaki
    Komatsu, Norio
    Kirito, Keita
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (02) : 215 - 227
  • [46] Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial
    Hiroaki Seino
    Diabetes Therapy, 2021, 12 : 863 - 877
  • [47] An open, multi-center, phase II clinical trial to evaluate efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer preliminary report.
    Chao, Y
    Li, CP
    Chao, TY
    Su, WC
    Hsieh, RK
    Wu, MF
    Yeh, KH
    Chen, LT
    Cheng, AL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 346S - 346S
  • [48] Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial
    Seino, Hiroaki
    DIABETES THERAPY, 2021, 12 (03) : 863 - 877
  • [49] A prospective, single-arm, open-label, phase II clinical trial on efficacy and safety of cadonilimab plus anlotinib for recurrent, metastatic or persistent cervical cancer
    Yang, Chunxu
    Sun, Shaoxing
    Xiang, Qingming
    Chen, Min
    Mei, Zijie
    Wu, Qiuji
    Qiu, Hui
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S290 - S290
  • [50] Efficacy and safety of eribulin plus gemcitabine in second-line or beyond for patients with HER2-negative metastatic breast cancer (MBC): A multi-center, open-label, single-arm, phase II study
    Peng, PeiJian
    Xu, Xiao-Lu
    Zhong, Jin-Cai
    Ye, Jin-Hui
    Wang, Zhi-Hui
    Wang, Hong
    Lin, Hong
    Du, Cai-Wen
    Zou, Guorong
    Ouyang, Jie
    Shi, Ying-Ying
    Xu, Fei
    Yu, Geng-Sheng
    Lu, Yong-Kui
    Wang, Yong-Xia
    Cui, Shi-En
    Li, Lu-Zhen
    CANCER RESEARCH, 2024, 84 (09)
12345